Brief: Innoviva Q4 EPS USD 0.76
29/02/2024 21:05
Feb 29 (Reuters) - Innoviva Q4 royalty revenue USD 66.165 million. * Q4 pretax profit USD 61.201 million * Q4 basic EPS USD 0.97 * Q4 net income USD 61.531 million
Recent news on Innoviva
See all newsInnoviva, Inc. reports results for the quarter ended June 30 - Earnings Summary
Innoviva Q2 revenue rises on higher net product sales
Brief: Innoviva Q2 Royalty Revenue USD 56.334 Million
Brief: Nortiva Bio Launches To Develop Long-Acting Oral Medicines
Brief: Innoviva Q1 Royalty Revenue USD 55.167 Million